Herbalife forecasts adjusted EBITDA of $670M-$690M for 2026 after reporting $1.3 billion in Q2 net sales.
Herbalife set a full-year 2026 adjusted EBITDA target of $670M-$690M, aligning with its long-term financial outlook. The company also announced plans for a CFO transition in 2027, though details remain undisclosed.
The guidance follows Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, matching the top end of its guidance range. CEO Stephan Gratziani highlighted strong performance but did not provide further context on market conditions or product-specific growth.
No immediate market reaction was disclosed in the earnings call summary.